Literature DB >> 18358572

Inulin supplementation prevents high fructose diet-induced hypertension in rats.

Marie-Hélène Rault-Nania1, Céline Demougeot, Elyett Gueux, Alain Berthelot, Stanislaw Dzimira, Yves Rayssiguier, Edmond Rock, Andrzej Mazur.   

Abstract

BACKGROUND & AIMS: The aim of this experiment was to evaluate the potential beneficial effect of supplementation with different inulin-type fructan fractions against common features of the metabolic syndrome in a rat model of this syndrome (fructose-fed rat).
METHODS: Forty Wistar rats were randomly divided into five groups and the animals received for 4 weeks either a semi-purified starch or fructose-based diet, or diets in which fructose was partially substituted with various fructans: 10 g/100 g of long-chain inulin or oligofructose, or an oligofructose-enriched inulin. After this period, blood pressure was measured and samples of blood and tissues were collected for selected biochemical analyses.
RESULTS: As compared to the starch-fed group, the fructose-fed rats presented: hypertriglyceridemia, hypertension, increased susceptibility to heart peroxidation and renal damages. Long-chain inulin and oligofructose-enriched inulin supplementation prevented fructose induced elevated blood pressure, susceptibility to heart peroxidation and renal damages. All inulin-type fructans containing diets prevented fructose induced hypertriglyceridemia.
CONCLUSIONS: These results suggest that supplementation with inulin-type fructans is efficient against fructose induced hypertension and that effects are most pronounced for long-chain inulin and oligofructose-enriched inulin. We hypothesize that the anti-hypertensive effect of inulin could be explained by the reduction of the high fructose induced oxidative stress.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18358572     DOI: 10.1016/j.clnu.2008.01.015

Source DB:  PubMed          Journal:  Clin Nutr        ISSN: 0261-5614            Impact factor:   7.324


  7 in total

1.  Troxerutin suppresses lipid abnormalities in the heart of high-fat-high-fructose diet-fed mice.

Authors:  Rajagopalan Geetha; Baskaran Yogalakshmi; S Sreeja; K Bhavani; Carani Venkatraman Anuradha
Journal:  Mol Cell Biochem       Date:  2013-10-31       Impact factor: 3.396

Review 2.  A review of the pharmacological effects of Arctium lappa (burdock).

Authors:  Yuk-Shing Chan; Long-Ni Cheng; Jian-Hong Wu; Enoch Chan; Yiu-Wa Kwan; Simon Ming-Yuen Lee; George Pak-Heng Leung; Peter Hoi-Fu Yu; Shun-Wan Chan
Journal:  Inflammopharmacology       Date:  2010-10-28       Impact factor: 4.473

Review 3.  Antihypertensive properties of plant-based prebiotics.

Authors:  Siok-Koon Yeo; Lay-Gaik Ooi; Ting-Jin Lim; Min-Tze Liong
Journal:  Int J Mol Sci       Date:  2009-08-10       Impact factor: 6.208

4.  The Relation between Fructose-Induced Metabolic Syndrome and Altered Renal Haemodynamic and Excretory Function in the Rat.

Authors:  Mohammed H Abdulla; Munavvar A Sattar; Edward J Johns
Journal:  Int J Nephrol       Date:  2011-07-12

Review 5.  The Role of Supplemental Complex Dietary Carbohydrates and Gut Microbiota in Promoting Cardiometabolic and Immunological Health in Obesity: Lessons from Healthy Non-Obese Individuals.

Authors:  Petra C Vinke; Sahar El Aidy; Gertjan van Dijk
Journal:  Front Nutr       Date:  2017-07-24

6.  Effects of Synbiotic Food Consumption on Serum Minerals, Liver Enzymes, and Blood Pressure in Patients with Type 2 Diabetes: A Double-blind Randomized Cross-over Controlled Clinical Trial.

Authors:  Zatollah Asemi; Mohammad Hossein Aarabi; Mohammad Hajijafari; Sabihe-Alsadat Alizadeh; Reza Razzaghi; Majid Mazoochi; Ahmad Esmaillzadeh
Journal:  Int J Prev Med       Date:  2017-06-01

7.  Inulin-type fructans supplementation improves glycemic control for the prediabetes and type 2 diabetes populations: results from a GRADE-assessed systematic review and dose-response meta-analysis of 33 randomized controlled trials.

Authors:  Long Wang; Hong Yang; Hao Huang; Chao Zhang; Hong-Xia Zuo; Pan Xu; Yu-Ming Niu; Shi-Shi Wu
Journal:  J Transl Med       Date:  2019-12-05       Impact factor: 5.531

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.